| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/04/2010 | US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 03/03/2010 | EP2158900A1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 03/03/2010 | EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671177 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 02/25/2010 | WO2010021351A1 Cycloalkylamine derivative |
| 02/25/2010 | WO2010020379A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 02/25/2010 | WO2009126923A3 Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof |
| 02/25/2010 | US20100048627 synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048526 Pharmaceutical composition for transdermal or transmucous administration |
| 02/25/2010 | US20100048525 Androgen treatment in females |
| 02/25/2010 | US20100048466 Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance |
| 02/25/2010 | US20100048455 Formulations For Therapeutic Administration Of Thyroid Stimulating Hormone (TSH) |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/24/2010 | CN101654470A Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/23/2010 | US7667040 Azacyclic ethynyl derivatives |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7666876 Buprenorphine formulations for intranasal delivery |
| 02/23/2010 | US7666873 N-phenyl-(2R,5S)dimethylpiperazine derivative |
| 02/23/2010 | US7666844 Dry mouldable drug formulation |
| 02/23/2010 | US7666838 Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes |
| 02/23/2010 | CA2297115C Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 02/18/2010 | WO2010017965A2 SOLID LIPID MICROCAPSULES CONTAINING hGH |
| 02/18/2010 | WO2010017743A1 The injectable sustained-release formulation of lhrh antagonists and the preparation thereof |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2009137534A3 Estrogenic extracts for use in treating vaginal and vulvar atrophy |
| 02/18/2010 | US20100041624 Buprenorphine formulations for intranasal delivery |
| 02/18/2010 | US20100041598 Use of Prolactin in the Prophylactic Treatment of Cancer |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/17/2010 | EP2153849A2 Contraception process and administration form for the same |
| 02/17/2010 | EP2152285A1 Composition for maintaining androgen and androgen-like uptake potential by cells |
| 02/17/2010 | EP1511737B1 Aryloximes |
| 02/17/2010 | CN100590133C Growth hormone and serum albumni recombinant fusion protein |
| 02/17/2010 | CN100590124C Tricyclic androgen receptor modulator compounds and method |
| 02/16/2010 | US7662851 Use of specific cyklolignans |
| 02/16/2010 | US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/16/2010 | US7662768 Transdifferentiation of pancreatic acinar cells |
| 02/16/2010 | US7662408 Sustained-release preparations |
| 02/16/2010 | US7662393 comprises alkali metal salt, alkaline earth metal salt, and citrate/phosphate buffer; improved stability |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
| 02/16/2010 | CA2447175C Use of estrogen compounds to increase libido in women |
| 02/16/2010 | CA2422267C Drying method for selectively removing volatile components from wet coatings |
| 02/16/2010 | CA2223701C Fgf9 as a specific ligand for fgfr3 |
| 02/11/2010 | WO2010016931A2 Polymorphs of fluticasone furoate and process for preparation thereof |
| 02/11/2010 | WO2010015529A1 New no releasing steroids derivatives |
| 02/11/2010 | WO2010015036A1 Biological applications of steroid binding domains |
| 02/11/2010 | US20100035805 Non-aqueous liquid formulation for nasal or buccal administration |
| 02/11/2010 | US20100034779 Compositions and methods for producing pluripotent cells from adult testis |
| 02/11/2010 | CA2733506A1 Biological applications of steroid binding domains |
| 02/11/2010 | CA2733006A1 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 02/11/2010 | CA2733005A1 Truncated analogues of glucose-dependent insulinotropic polypeptide |
| 02/11/2010 | CA2732973A1 Glucose-dependent insulinotropic polypeptide analogues |
| 02/11/2010 | CA2732949A1 Analogues of glucose-dependent insulinotropic polypeptide |
| 02/11/2010 | CA2731477A1 New no releasing steroids derivatives |
| 02/10/2010 | EP2151440A1 Heterocyclic compound and use thereof |
| 02/10/2010 | EP2151436A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
| 02/10/2010 | EP2151236A1 G-protein-conjugated receptor agonist |
| 02/10/2010 | EP2150558A1 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 02/10/2010 | CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |
| 02/09/2010 | CA2570103C Method of increasing growth hormone secretion |
| 02/09/2010 | CA2440588C Chronotherapeutic dosage forms |
| 02/09/2010 | CA2403756C Structural modification of 19-norprogesterone i: 17-.alpha.-substituted, 11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 02/09/2010 | CA2386297C Bicyclic amino acids as pharmaceutical agents |
| 02/09/2010 | CA2378431C Peptides that lower blood glucose levels |
| 02/04/2010 | WO2010013762A1 Metastin derivative and use thereof |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 02/04/2010 | WO2010013494A1 Pharmaceutical composition comprising botulinum neurotoxin preparation incapable of being synaptically transported, and use thereof |
| 02/04/2010 | WO2010012567A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 02/04/2010 | WO2010012396A1 5,6 substituted benzamide derivatives as modulators of the ep<sb>2 </sb>receptor |
| 02/04/2010 | US20100029694 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/04/2010 | US20100029687 Piperidine derivative or salt thereof |
| 02/04/2010 | US20100029603 16alpha-methyl or ethyl substituted estrogens |
| 02/04/2010 | US20100029548 Glycoproteins produced in plants and methods of their use |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | CA2731513A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/03/2010 | EP2149552A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2148685A2 Methods and compounds for vitamin d therapy |
| 02/03/2010 | EP2148681A2 Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding |
| 02/03/2010 | EP2148660A2 Sustained release |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN101638437A Growth hormone fusion protein |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655653 Tetrahydrobenzfluorene derivatives |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 01/28/2010 | WO2010009828A1 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 01/28/2010 | WO2009140665A3 Identification of a molecular signature for antipsychotics and serms |
| 01/28/2010 | WO2009111428A4 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof |
| 01/28/2010 | US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 01/28/2010 | US20100022641 Solid forms of selective androgen receptor modulators |
| 01/28/2010 | US20100022632 Use certain diterpene compounds in the treatment of androgen receptor-associated diseases |
| 01/28/2010 | US20100022565 Pharmaceutical compositions |
| 01/28/2010 | US20100022494 Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |
| 01/28/2010 | US20100022488 Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |
| 01/28/2010 | US20100022487 Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |